Inspire Medical Systems (NYSE:INSP) Announces Earnings Results, Beats Expectations By $0.41 EPS

Inspire Medical Systems (NYSE:INSP) released its quarterly earnings results on Monday. The company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.41, Zacks reports. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%.

Inspire Medical Systems Stock Down 0.7 %

Shares of Inspire Medical Systems stock opened at $180.96 on Tuesday. Inspire Medical Systems has a 12 month low of $123.00 and a 12 month high of $257.40. The business has a fifty day simple moving average of $189.72 and a 200 day simple moving average of $190.66. The stock has a market cap of $5.42 billion, a PE ratio of 169.12 and a beta of 1.32.

Analysts Set New Price Targets

INSP has been the subject of a number of research reports. Robert W. Baird raised their target price on Inspire Medical Systems from $240.00 to $252.00 and gave the company an “outperform” rating in a research note on Tuesday, November 5th. Bank of America raised shares of Inspire Medical Systems from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $220.00 to $255.00 in a research note on Wednesday, November 20th. Royal Bank of Canada reissued an “outperform” rating and set a $260.00 price target on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Stifel Nicolaus dropped their price objective on shares of Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating for the company in a research report on Tuesday, January 21st. Finally, Wells Fargo & Company upped their price objective on Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, Inspire Medical Systems currently has an average rating of “Moderate Buy” and an average price target of $229.00.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.